Evidence map›Paper›PMID 35367364›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022

Impact of COVID-19 and malaria coinfection on clinical outcomes: a retrospective cohort study.

Rasha Hussein, Murilo Guedes, Nada Ibraheim, Mazin M Ali, Amal El-Tahir, Nahla Allam, Hussain Abuakar, Roberto Pecoits-Filho, Peter Kotanko

Open access · hybridAbstract read
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Circulation of SARS-CoV-2 and Co-Infection withInfectious disease reports · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Malaria and COVID-19 coinfection in a non-malaria-endemic area in Brazil.Revista da Sociedade Brasileira de Medicina Tropical · 2023
    Article
  15. SARS-CoV-2 decreases malaria severity in co-infected rodent models.Frontiers in cellular and infection microbiology · 2023
    Article
  16. Review
  17. Article
  18. Co-Infection withTropical medicine and infectious disease · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Rasha HusseinUniversal COVID-19 Treatment Centre, Ministry of Health, Khartoum State, Sudan; Ministry of Health, Khartoum State, Sudan; School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil; Soba University Hospital, Khartoum, Sudan.
Murilo GuedesSchool of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
Nada IbraheimUniversal COVID-19 Treatment Centre, Ministry of Health, Khartoum State, Sudan.
Mazin M AliUniversal COVID-19 Treatment Centre, Ministry of Health, Khartoum State, Sudan.
Amal El-TahirMinistry of Health, Khartoum State, Sudan.
Nahla AllamSoba University Hospital, Khartoum, Sudan; Faculty of Medicine, Al Neelain University, Khartoum, Sudan.
Hussain AbuakarUniversal COVID-19 Treatment Centre, Ministry of Health, Khartoum State, Sudan.
Roberto Pecoits-FilhoSchool of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil; Ann Arbor Research Collaborative for Health, Ann Arbor, MI, United States.
Peter KotankoRenal Research Institute, New York, NY, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: Peter.Kotanko@RRINY.COM.
Federal Ministry of Health · SDPontifícia Universidade Católica do Paraná · BRAl-Neelain University · SDIcahn School of Medicine at Mount Sinai · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDespite the possibility of concurrent infection with COVID-19 and malaria, little is known about the clinical course of coinfected patients. We analysed the clinical outcomes of patients with concurrent COVID-19 and malaria infection.

methodsWe conducted a retrospective cohort study that assessed prospectively collected data of all patients who were admitted between May and December 2020 to the Universal COVID-19 treatment center (UCTC), Khartoum, Sudan. UCTC compiled demographic, clinical, laboratory (including testing for malaria), and outcome data in all patients with confirmed COVID-19 hospitalized at that clinic. The primary outcome was all-cause mortality during the hospital stay. We built proportional hazard Cox models with malaria status as the main exposure and stepwise adjustment for age, sex, cardiovascular comorbidities, diabetes, and hypertension.

resultsWe included 591 patients with confirmed COVID-19 diagnosis who were also tested for malaria. Mean (SD) age was 58 (16.2) years, 446/591 (75.5%) were males. Malaria was diagnosed in 270/591 (45.7%) patients. Most malaria patients were infected by Plasmodium falciparum (140/270; 51.9%), while 121/270 (44.8%) were coinfected with Plasmodium falciparum and Plasmodium vivax. Median follow-up was 29 days. Crude mortality rates were 10.71 and 5.87 per 1000 person-days for patients with and without concurrent malaria, respectively. In the fully adjusted Cox model, patients with concurrent malaria and COVID-19 had a greater mortality risk (hazard ratio 1.43, 95% confidence interval 1.21-1.69). DISCUSSION: Coinfection with COVID-19 and malaria is associated with increased all-cause in-hospital mortality compared to monoinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Indexed as

CoinfectionCOVID-19COVID-19 Drug TreatmentMalariaCOVID-19 TestingFemaleHumansMaleMiddle AgedRetrospective StudiesSARS-CoV-2Acute kidney injuryClinical outcomesCoinfectionCOVID-19MalariaMortalitySARS-CoV-2Sub-Saharan Africa

Identifiers

PMID35367364
PMCPMC8968160
OpenAlexW4220736531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.